Colleen A. Fordyce, Ph.D. - Publications

Affiliations: 
2002 University of New Mexico, Albuquerque, NM, United States 
Area:
Molecular Biology, Biochemistry, Oncology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 DeFilippis RA, Fordyce C, Patten K, Chang H, Zhao J, Fontenay GV, Kerlikowske K, Parvin B, Tlsty TD. Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density. Cancer Research. 74: 5032-44. PMID 25172842 DOI: 10.1158/0008-5472.Can-13-3390  0.68
2012 Fordyce CA, Patten KT, Fessenden TB, DeFilippis R, Hwang ES, Zhao J, Tlsty TD. Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes. Breast Cancer Research : Bcr. 14: R155. PMID 23216814 DOI: 10.1186/Bcr3368  0.68
2010 Fordyce C, Fessenden T, Pickering C, Jung J, Singla V, Berman H, Tlsty T. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. Cancer Prevention Research (Philadelphia, Pa.). 3: 190-201. PMID 20028875 DOI: 10.1158/1940-6207.Capr-09-0229  0.68
2009 Dumont N, Crawford YG, Sigaroudinia M, Nagrani SS, Wilson MB, Buehring GC, Turashvili G, Aparicio S, Gauthier ML, Fordyce CA, McDermott KM, Tlsty TD. Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy. Breast Cancer Research : Bcr. 11: R87. PMID 19995452 DOI: 10.1186/Bcr2457  0.68
2006 Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK. Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Research and Treatment. 99: 193-202. PMID 16752076 DOI: 10.1007/S10549-006-9204-1  0.68
2006 Heaphy CM, Bisoffi M, Fordyce CA, Haaland CM, Hines WC, Joste NE, Griffith JK. Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. International Journal of Cancer. 119: 108-16. PMID 16450377 DOI: 10.1002/Ijc.21815  0.68
2005 Berman H, Zhang J, Crawford YG, Gauthier ML, Fordyce CA, McDermott KM, Sigaroudinia M, Kozakiewicz K, Tlsty TD. Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis. Cold Spring Harbor Symposia On Quantitative Biology. 70: 317-27. PMID 16869768 DOI: 10.1101/Sqb.2005.70.051  0.68
2005 Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Research. 65: 1792-9. PMID 15753376 DOI: 10.1158/0008-5472.Can-04-3507  0.68
2005 Fordyce CA, Heaphy CM, Joste NE, Smith AY, Hunt WC, Griffith JK. Association between cancer-free survival and telomere DNA content in prostate tumors. The Journal of Urology. 173: 610-4. PMID 15643274 DOI: 10.1097/01.Ju.0000143195.49685.Ce  0.72
2004 Tlsty TD, Crawford YG, Holst CR, Fordyce CA, Zhang J, McDermott K, Kozakiewicz K, Gauthier ML. Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. Journal of Mammary Gland Biology and Neoplasia. 9: 263-74. PMID 15557799 DOI: 10.1023/B:Jomg.0000048773.95897.5F  0.68
2002 Fordyce CA, Heaphy CM, Griffith JK. Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques. 33: 144-6, 148. PMID 12139239 DOI: 10.2144/02331Md02  0.72
1999 Griffith JK, Bryant JE, Fordyce CA, Gilliland FD, Joste NE, Moyzis RK. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Research and Treatment. 54: 59-64. PMID 10369081 DOI: 10.1023/A:1006128228761  0.68
1994 Griffith JK, Cuellar DH, Fordyce CA, Hutchings KG, Mondragon AA. Structure and function of the class C tetracycline/H+ antiporter: three independent groups of phenotypes are conferred by TetA (C). Molecular Membrane Biology. 11: 271-7. PMID 7711837 DOI: 10.3109/09687689409160437  0.72
Show low-probability matches.